CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.90 +0.06 (+6.75%)
At close: Oct 1, 2026 · 4:00 PM EDT

CytoMed Therapeutics (GDTC) Revenue (2024 - 2025)

Updated

CytoMed Therapeutics' Revenue was $248,285 in FY2025, up 377.2% from $52,029 in FY2024.

Analysis

CytoMed Therapeutics (GDTC) Revenue (2024 - 2025) Analysis & Trends

From FY2021 onward, CytoMed Therapeutics has reported Revenue for 5 years.

  • Revenue shows a four-year compound annual growth rate of -18.2% (FY2021 to FY2025).
  • Annual Revenue has moved between $52,029 (FY2024) and $569,244 (FY2022) over five years.
  • Per Business Quant data, Revenue in earlier years was $52,029 in FY2024 (-89.0%), $473,813 in FY2023 (-16.8%), $569,244 in FY2022 (+2.5%) and $555,413 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.31 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 16.99 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 16.61 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 14.41 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 15.38 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 10.05 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 7.80 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 15.03 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 3.33 Bn
10 CytoMed Therapeutics 9.94 Mn -1.15 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 11,621.00
Jun 30, 2024 8,639.00
API Access

CytoMed Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=GDTC&period=max&api_key=YOUR_API_KEY